Laparoscopic adrenalectomy for malignant tumors

Masatoshi Eto, Masumitsu Hamaguchi, Masahiko Harano, Akira Yokomizo, Katsunori Tatsugami, Seiji Naito

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Objectives: The treatment of malignant adrenal tumors using laparoscopic surgery remains controversial. We thus compared the perioperative outcome of the laparoscopic adrenalectomy for the treatment of malignant tumors with the outcome for benign tumors. We also evaluated the oncological outcome of the laparoscopic adrenalectomy for a malignancy. Methods: Since 1999 a total of nine laparoscopic adrenalectomies for a malignancy have been performed in nine patients. The median adrenal tumor size was 3 cm. The laparoscopic approach was transperitoneal in all cases. Seven patients had no evidence of a systemic metastatic disease, whereas two patients with a metastatic renal cell carcinoma had systemic metastatic disease at the time of the operation. Results: The median operation time was 165 min and the estimated blood loss was 75 mL in the laparoscopic adrenalectomy for a malignancy. There was no significant difference between laparoscopic adrenalectomy for malignant and benign tumors. Regarding the oncological outcome, seven of the nine patients, including the two palliative cases, treated with a laparoscopic adrenalectomy for a malignancy were alive at a median follow-up of 20 months. One patient died of other causes. Conclusions: Our results clearly indicate that a laparoscopic adrenalectomy for the treatment of a metastatic adrenal malignancy can be performed with an acceptable outcome as a minimally invasive method in carefully selected patients.

Original languageEnglish
Pages (from-to)295-298
Number of pages4
JournalInternational Journal of Urology
Volume15
Issue number4
DOIs
Publication statusPublished - Apr 1 2008

Fingerprint

Adrenalectomy
Neoplasms
Glandular and Epithelial Neoplasms
Renal Cell Carcinoma
Laparoscopy
Therapeutics

All Science Journal Classification (ASJC) codes

  • Urology

Cite this

Laparoscopic adrenalectomy for malignant tumors. / Eto, Masatoshi; Hamaguchi, Masumitsu; Harano, Masahiko; Yokomizo, Akira; Tatsugami, Katsunori; Naito, Seiji.

In: International Journal of Urology, Vol. 15, No. 4, 01.04.2008, p. 295-298.

Research output: Contribution to journalArticle

Eto, Masatoshi ; Hamaguchi, Masumitsu ; Harano, Masahiko ; Yokomizo, Akira ; Tatsugami, Katsunori ; Naito, Seiji. / Laparoscopic adrenalectomy for malignant tumors. In: International Journal of Urology. 2008 ; Vol. 15, No. 4. pp. 295-298.
@article{cc3a020d295649d79cee479c62e81555,
title = "Laparoscopic adrenalectomy for malignant tumors",
abstract = "Objectives: The treatment of malignant adrenal tumors using laparoscopic surgery remains controversial. We thus compared the perioperative outcome of the laparoscopic adrenalectomy for the treatment of malignant tumors with the outcome for benign tumors. We also evaluated the oncological outcome of the laparoscopic adrenalectomy for a malignancy. Methods: Since 1999 a total of nine laparoscopic adrenalectomies for a malignancy have been performed in nine patients. The median adrenal tumor size was 3 cm. The laparoscopic approach was transperitoneal in all cases. Seven patients had no evidence of a systemic metastatic disease, whereas two patients with a metastatic renal cell carcinoma had systemic metastatic disease at the time of the operation. Results: The median operation time was 165 min and the estimated blood loss was 75 mL in the laparoscopic adrenalectomy for a malignancy. There was no significant difference between laparoscopic adrenalectomy for malignant and benign tumors. Regarding the oncological outcome, seven of the nine patients, including the two palliative cases, treated with a laparoscopic adrenalectomy for a malignancy were alive at a median follow-up of 20 months. One patient died of other causes. Conclusions: Our results clearly indicate that a laparoscopic adrenalectomy for the treatment of a metastatic adrenal malignancy can be performed with an acceptable outcome as a minimally invasive method in carefully selected patients.",
author = "Masatoshi Eto and Masumitsu Hamaguchi and Masahiko Harano and Akira Yokomizo and Katsunori Tatsugami and Seiji Naito",
year = "2008",
month = "4",
day = "1",
doi = "10.1111/j.1442-2042.2008.01997.x",
language = "English",
volume = "15",
pages = "295--298",
journal = "International Journal of Urology",
issn = "0919-8172",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Laparoscopic adrenalectomy for malignant tumors

AU - Eto, Masatoshi

AU - Hamaguchi, Masumitsu

AU - Harano, Masahiko

AU - Yokomizo, Akira

AU - Tatsugami, Katsunori

AU - Naito, Seiji

PY - 2008/4/1

Y1 - 2008/4/1

N2 - Objectives: The treatment of malignant adrenal tumors using laparoscopic surgery remains controversial. We thus compared the perioperative outcome of the laparoscopic adrenalectomy for the treatment of malignant tumors with the outcome for benign tumors. We also evaluated the oncological outcome of the laparoscopic adrenalectomy for a malignancy. Methods: Since 1999 a total of nine laparoscopic adrenalectomies for a malignancy have been performed in nine patients. The median adrenal tumor size was 3 cm. The laparoscopic approach was transperitoneal in all cases. Seven patients had no evidence of a systemic metastatic disease, whereas two patients with a metastatic renal cell carcinoma had systemic metastatic disease at the time of the operation. Results: The median operation time was 165 min and the estimated blood loss was 75 mL in the laparoscopic adrenalectomy for a malignancy. There was no significant difference between laparoscopic adrenalectomy for malignant and benign tumors. Regarding the oncological outcome, seven of the nine patients, including the two palliative cases, treated with a laparoscopic adrenalectomy for a malignancy were alive at a median follow-up of 20 months. One patient died of other causes. Conclusions: Our results clearly indicate that a laparoscopic adrenalectomy for the treatment of a metastatic adrenal malignancy can be performed with an acceptable outcome as a minimally invasive method in carefully selected patients.

AB - Objectives: The treatment of malignant adrenal tumors using laparoscopic surgery remains controversial. We thus compared the perioperative outcome of the laparoscopic adrenalectomy for the treatment of malignant tumors with the outcome for benign tumors. We also evaluated the oncological outcome of the laparoscopic adrenalectomy for a malignancy. Methods: Since 1999 a total of nine laparoscopic adrenalectomies for a malignancy have been performed in nine patients. The median adrenal tumor size was 3 cm. The laparoscopic approach was transperitoneal in all cases. Seven patients had no evidence of a systemic metastatic disease, whereas two patients with a metastatic renal cell carcinoma had systemic metastatic disease at the time of the operation. Results: The median operation time was 165 min and the estimated blood loss was 75 mL in the laparoscopic adrenalectomy for a malignancy. There was no significant difference between laparoscopic adrenalectomy for malignant and benign tumors. Regarding the oncological outcome, seven of the nine patients, including the two palliative cases, treated with a laparoscopic adrenalectomy for a malignancy were alive at a median follow-up of 20 months. One patient died of other causes. Conclusions: Our results clearly indicate that a laparoscopic adrenalectomy for the treatment of a metastatic adrenal malignancy can be performed with an acceptable outcome as a minimally invasive method in carefully selected patients.

UR - http://www.scopus.com/inward/record.url?scp=41749106660&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41749106660&partnerID=8YFLogxK

U2 - 10.1111/j.1442-2042.2008.01997.x

DO - 10.1111/j.1442-2042.2008.01997.x

M3 - Article

C2 - 18380814

AN - SCOPUS:41749106660

VL - 15

SP - 295

EP - 298

JO - International Journal of Urology

JF - International Journal of Urology

SN - 0919-8172

IS - 4

ER -